This inventor holds 15 USPTO granted patents and 5 published patent applications and 5 EPO patents, primarily in Oncolytic Virus Therapy. Top assignees: Genelux Corporation, Beckman Research Institute, City of Hope, California Institute of Technology. Active years: 2011-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
10 out of 30 
5 out of 692 
3 out of 4,632 
Years Active: 2011-2026
Areas of Expertise:
Title: **The Innovations of Inventor Nanhai G Chen**
Introduction
Nanhai G Chen, based in San Diego, California, is a prominent inventor known for his significant contributions to the field of biotechnology. With an impressive portfolio of 14 patents, he has established himself as a pioneer in developing innovative treatments for various diseases, particularly in oncology.
Latest Patents
Among his latest patents, Chen has developed groundbreaking technologies, such as an oncolytic virus expressing a CAR T cell target. This patent details the use of an oncolytic poxvirus encoding a truncated human CD19, which is employed in conjunction with a chimeric antigen receptor to treat solid tumors. Additionally, his patent on clonal strains of attenuated vaccinia viruses highlights methods of identifying and isolating such strains from virus preparations. These innovations not only open new avenues for cancer therapies but also enhance the diagnostic capabilities for proliferative disorders, including solid tumors and blood cancers.
Career Highlights
Throughout his career, Nanhai G Chen has worked with notable organizations such as Genelux Corporation and the City of Hope. His research and development initiatives have greatly contributed to advancements in medical science, particularly in the innovative use of viruses in treating malignancies. His expertise and dedication to improving patient outcomes through biotechnological innovations position him as a vital figure in the field.
Collaborations
Chen has collaborated with several esteemed colleagues, including Aladar A Szalay and Yong A Yu. These partnerships have been instrumental in driving forward research initiatives and expanding the horizons of biotechnology applications in medicine. Through collective efforts, they have fostered an environment conducive to groundbreaking discoveries that enhance therapeutic protocols.
Conclusion
Nanhai G Chen's work exemplifies the spirit of innovation in biotechnology. His contributions, characterized by 14 patents, signify a commitment to addressing critical health challenges and improving patient care. As research continues to evolve, his legacy of developing transformative therapies will undoubtedly influence future advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile